PRODUCTS & INNOVATION
Abbott’s breakthrough roadside drug-screening tool earns spot on Popular Science’s “Best of What’s New in 2019” innovation awards.
Dec 3 2019
Popular Science calls our SoToxa™ Mobile Test System – Abbott’s roadside drug-screening device – one of the top ten game-changing innovations in the Health category for 2019.
The device is being recognized as an innovative solution to help combat drug-impaired driving and keep roadways safe as part of the 2019 “Best of What’s New Awards.” Each year, Popular Science editors search to find the top 100 innovations—exemplary breakthrough products and technologies that demonstrate significant advancement in their respective categories.
SoToxa is a handheld device for law enforcement that uses an oral fluid swab – inserted into the handheld analyzer – that alerts police within five minutes whether a driver has recently used marijuana or other drugs. Because it collects only a small amount of oral fluid, the device is easier to administer than blood or urine tests, making it significantly easier for law enforcement to conduct the tests at the roadside, or in a police cruiser.
SoToxa is able to test for the presence of THC (the psychoactive component in marijuana), cocaine, opioids, amphetamine, methamphetamine, and benzodiazepines. Because it provides rapid, accurate results, the mobile analyzer helps law enforcement agencies remove suspected drug-impaired drivers from the road quickly. And because SoToxa is handheld and highly durable, the technology holds up to the rigors of roadside drug screening.
“An increasing number of driving fatalities over the past decade are associated with drug use, and more states either have or will soon legalize recreational marijuana,1” said Chris Scoggins, Senior Vice President, Rapid Diagnostics, Abbott. “That’s why we’re working with law enforcement and lawmakers to bring this life-changing technology to the roadside. SoToxa is tested, validated and ready now, arming police with critical information to help them make quick and informed decisions that will ultimately help make roads safer for everyone.”
As more states across the U.S. legalize marijuana for recreational use, the public’s demand for roadside testing tools, such as SoToxa, is underscored by findings from a recent survey released by Abbott. The study found that almost two-thirds of Americans (64%) are concerned about an increase in drugged-driving crashes, while more than 1 in 5 Americans (21%) know someone who has been in a car crash involving a driver who was under the influence of drugs.2
Learn more about SoToxa here.
2 Abbott survey, June 2019
Conducting Research During a Pandemic
Reducing Risk by Diagnosing with Reliable Point-of-Care Testing
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.